Post-IPO Equity - Outlook Therapeutics - May 26, 2020 Funding Round Profile - Cointime

Bitcoin $80,243.33 +5.48%
Ethereum $3,226.99 +6.81%
BNB $641.57 +4.15%
Optimism $1.72 +8.81%
Arbitrum $0.65 +10.37%
Solana $212.54 +7.84%
Polygon $0.42 +10.58%
Cosmos $5.49 +17.61%
Avalanche $32.89 +14.29%

Bitcoin $80,243.33 +5.48%
Ethereum $3,226.99 +6.81%
BNB $641.57 +4.15%
Optimism $1.72 +8.81%
Arbitrum $0.65 +10.37%
Solana $212.54 +7.84%
Polygon $0.42 +10.58%
Cosmos $5.49 +17.61%
Avalanche $32.89 +14.29%

Outlook Therapeutics

company

Funding Round

Post-IPO Equity

Money Raised

$ 27.20M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Syntone Ventures	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jul 27, 2015	Series Unknown	$ 31M	Cormorant Global Healthcare Master Fund,Longwood Capital Partners,etc.	Detail
Nov 5, 2018	Post-IPO Equity	$ 20M	Biolexis	Detail
Sep 29, 2015	Series Unknown	0	Cormorant Global Healthcare Master Fund,Longwood Capital Partners,etc.	Detail
Feb 24, 2020	Post-IPO Equity	$ 10.20M		Detail
May 14, 2018	Post-IPO Equity	$ 15M	GMS Tenshi Holdings	Detail
May 13, 2016	IPO	$ 35M		Detail